MetaCap

Astrana Health (ASTH) vs Insperity (NSP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Insperity (NSP) has outperformed Astrana Health (ASTH) over the past year, gaining 40.4% versus a gain of 28.4%. Over five years, NSP leads with a -58.2% price change compared with -69.4% for ASTH. Insperity is the larger company by market cap ($1.84 billion vs $1.44 billion), about 1.3 times the size, while Astrana Health is growing revenue faster (+56.4% vs +3.5%).

On valuation, Astrana Health trades at a lower forward P/E (8.3x vs 18.6x for Insperity). Insperity pays a dividend yielding 4.96%, while Astrana Health does not currently pay one. Astrana Health converts more of its revenue into profit, with a net margin of 0.7% versus -0.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASTH+28.44%NSP+40.39%
+130%+40%-50%
Nov 21, 20251 yearNov 20, 2026
ASTH-74.53%NSP-58.83%
+15%-37%-88%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASTH versus NSP key metrics
MetricASTHNSP
Share price$28.90$48.38
Market cap$1.44B$1.84B
1-day change+0.77%+2.33%
YTD return+16.49%+24.95%
1-year return+28.44%+40.39%
5-year return-69.44%-58.20%
P/E ratio (TTM)26.76691.14
Forward P/E8.3018.61
EPS (TTM)$1.08$0.07
Dividend yield0.00%4.96%
Annual dividend$0.00$2.40
Revenue (latest FY)$3.18B$6.81B
Revenue growth (YoY)+56.39%+3.51%
Net income (latest FY)$22.49M$-7.00M
Gross margin10.73%13.21%
Operating margin2.47%-0.15%
Net margin0.71%-0.10%
52-week high$51.60$55.90
52-week low$18.08$18.57
Distance from 52-week high-43.99%-13.45%
Analyst consensusstrong_buyhold
Avg. price target upside+79.55%+10.07%
Average volume377.18K410.34K
Shares outstanding49.67M38.10M
Employees3,000305,359
SectorConsumer DiscretionaryConsumer Discretionary
IndustryProfessional ServicesProfessional Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NSP has outperformed ASTH by 12.0 percentage points over the past year.
  • Insperity trades at a higher earnings multiple (691.1x vs 26.8x trailing P/E).
  • Insperity offers a meaningfully higher dividend yield (4.96% vs 0.00%).
  • Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs +3.51%).

About Astrana Health

ASTH stock →

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.

Consumer Discretionary · Professional Services · 3,000 employees

About Insperity

NSP stock →

Insperity, Inc. engages in the provision of human resources (HR) and business solutions to improve business performance for small and medium-sized businesses primarily in the United States.

Consumer Discretionary · Professional Services · 305,359 employees

ASTH vs NSP FAQ

Which is bigger, Astrana Health or Insperity?

Insperity (NSP) is larger, with a market capitalization of $1.84B compared with $1.44B for Astrana Health (ASTH).

Which stock has performed better over the past year, ASTH or NSP?

NSP returned +40.39% over the past 12 months, compared with +28.44% for ASTH (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ASTH or NSP?

ASTH has the lower trailing P/E at 26.8, versus 691.1 for NSP. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Astrana Health or Insperity?

Insperity pays a dividend yielding 4.96%, while Astrana Health does not currently pay a regular dividend.

Are Astrana Health and Insperity in the same industry?

Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.

More comparisons